Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study.
Hitoshi IshiiYukiko OnishiTomonori OuraMasakazu TakeuchiPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Eli Lilly and Company.